Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to study the effects of GH on body composition, lipid and glucose
metabolism, physical performance and safety aspects in adults with PWS.The patients are
randomized to either GH or placebo the first year of the study, subsequently followed by two
years of GH treatment. the study is performed in Norway, Sweden and Denmark.